SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015834
Filing Date
2023-09-18
Accepted
2023-09-18 06:35:37
Documents
15
Period of Report
2023-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20230918x8k.htm   iXBRL 8-K 43635
2 EX-99.1 imgn-20230918xex99d1.htm EX-99.1 14191
3 GRAPHIC imgn-20230918xex99d1001.jpg GRAPHIC 7018
  Complete submission text file 0001558370-23-015834.txt   198371

Data Files

Seq Description Document Type Size
4 EX-101.SCH imgn-20230918.xsd EX-101.SCH 4031
5 EX-101.DEF imgn-20230918_def.xml EX-101.DEF 3238
6 EX-101.LAB imgn-20230918_lab.xml EX-101.LAB 16596
7 EX-101.PRE imgn-20230918_pre.xml EX-101.PRE 9755
9 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20230918x8k_htm.xml XML 4642
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 231260073
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences